Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, today announced an update to the prescribing information for ELEVIDYS (delandistrogene moxeparvovec-rokl), the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback